
GC38949
Thalidomide-PEG2-C2-NH2 TFA
Also listed as Thalidomide-NH-PEG2-C2-NH2 TFA
Thalidomide-NH-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology
ChemicalCAS2097509-36-7MW518.44FormulaC21H25F3N4O8
- CAS number
- 2097509-36-7
- Molecular weight
- 518.44
- Formula
- C21H25F3N4O8
- Solubility
- Soluble in DMSO
- InChIKey
- MKEOTJQAATZPDV-UHFFFAOYSA-N
- Catalogue number
- GC38949
- Brand
- GLPBIO
Computed properties PubChem CID 132260540 · TPSA 177 Ų · H-bond donors 4 · H-bond acceptors 13
- TPSA
- 177 Ų
- H-bond donors
- 4
- H-bond acceptors
- 13
- Rotatable bonds
- 10
- Heavy atoms
- 36
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCOCCOCCN.C(=O)(C(F)(F)F)O
Computed descriptors from PubChem (CID 132260540), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il